| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 31.08. | Stryker to acquire ZuriMed to boost shoulder offerings | ||
| 31.08. | Edwards Lifesciences strategy VP will leave next year | ||
| 31.08. | Olympus launches Powerseal open extended jaw device | ||
| 31.08. | Medtronic recalls pH monitoring capsules after 184 serious injuries | ||
| 31.08. | GE HealthCare releases new Vivid technologies for cardiovascular imaging | ||
| 28.08. | Johnson & Johnson recalls Automated Impella Controllers after 3 patient deaths | ||
| 27.08. | The top 5 Medtronic stories of 2026 - so far | ||
| 27.08. | Paradromics gets FDA nod to expand BCI compatibility to personal devices | ||
| 27.08. | Fresenius study reports lower mortality risk with hemodiafiltration compared to standard dialysis | ||
| 27.08. | Abbott's next-generation Amulet LAA occlusion device earns CE Mark | ||
| 27.08. | Philips, Imricor launch MR-guided cardiac intervention technology | ||
| 26.08. | Philips receives $33.7M from ARPA-H autonomous robotic stroke surgery effort | ||
| 26.08. | Electromed CEO announces retirement | ||
| 25.08. | Boston Scientific reportedly hit with global network communications outage | ||
| 25.08. | Otsuka ICU Medical breaks ground on 500,000 square foot Austin site expansion | ||
| 25.08. | Royal Philips prices EUR 650 million EU Green Bond | ||
| 25.08. | CVRx has an activist investor urging it to get acquired | ||
| 24.08. | Former DePuy Synthes U.S. president joins Peptilogics board | ||
| 24.08. | CVRx earns new Medicare Advantage coverage policy for Barostim | ||
| 24.08. | FDA clears Roche's Alzheimer's blood test for rule-in and rule-out assessment | ||
| 21.08. | MiniMed Flex now integrated with Abbot's Instinct sensor | ||
| 21.08. | Siemens Healthineers wins $31 million in ARPA-H funding to develop remote robotic stroke treatment | ||
| 21.08. | Medtronic continues record of increasing dividend payment | ||
| 20.08. | Siemens Healthineers and Cleveland Clinic announce new 10 year alliance | ||
| 20.08. | FDA considers 'competency-based' evaluations for GenAI-enabled medical devices |